A Retrospective Study of 186 Patients Reveals the Strongest Immunity in the Early Two Years of Life Against Coronavirus Disease 2019
Qiu Li(Macau University of Science and Technology), Qibin Leng(State Key Laboratory of Respiratory Disease), Chengdong Zhang(North Sichuan Medical University), Mengdie Lü(State Key Laboratory of Respiratory Disease), Chenghao Hu(Hubei University of Medicine), Qiwen Duan(Hubei University of Medicine), Chunli Chen(Northeast Agricultural University), Jie Luo(Memorial Sloan Kettering Cancer Center), Xinzhou Deng(Hubei University of Medicine), Li Gong(Hubei University of Medicine), Jingfeng Li(Hubei University of Medicine), Junbo Wu(Tianjin University), Jian Xiong(Hubei University of Medicine), Zhiguo Luo(Hubei University of Medicine), Jingjing Chai(Hubei University of Medicine), Qing Ke(Hubei University of Medicine), Mihai G. Netea(Radboud University Nijmegen), Ming Luo(Hubei University of Medicine), Shen Li(Tianjin Anding Hospital), Rui Fu, Zhenwei Peng(Peking University)
Cited by 2
Related Papers
COVID-19 in patients with lung cancer
|Annals of Oncology|2020|269
Enhanced Transport of Shape and Rigidity-Tuned α-Lactalbumin Nanotubes across Intestinal Mucus and Cellular Barriers
|Nano Letters|2020|232
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
The delivery of sensitive food bioactive ingredients: Absorption mechanisms, influencing factors, encapsulation techniques and evaluation models
|Food Research International|2019|214
Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
|Journal of Clinical Investigation|2020|210